LUCAR-G79D T cells Therapy (Legend Biotechnology)

N/A

Report date: 2026/01/14 20:00:44

Base Information

Drug NameLUCAR-G79D T cells Therapy (Legend Biotechnology)
Drug Alias NameLUCAR-G79D
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, SystemicMyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Legend Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Legend Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicMyositis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A